Recent News

• 02.14.2025 - IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
• 02.14.2025 - IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
• 02.13.2025 - 2025 Tandem Meetings | Transplantation & CellularTherapy Meetings of ASTCT and CIBMTR
• 02.13.2025 - 2025 Tandem Meetings | Transplantation & CellularTherapy Meetings of ASTCT and CIBMTR
• 02.11.2025 - IN8bio Investor Call
• 02.11.2025 - IN8bio Investor Call
• 02.11.2025 - IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
• 02.11.2025 - IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
• 01.14.2025 - Biotech Showcase 2025
• 01.14.2025 - Biotech Showcase 2025

Recent Filings

• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.11.2025 - EX-99.1 EX-99.1
• 02.11.2025 - 8-K Current report
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 8-K Current report
• 01.31.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors